{"id":"syndros","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL465","moleculeType":"Small molecule","molecularWeight":"314.47"},"aliases":["Dronabinol"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"a7801c70-995d-46a2-91ee-141ef427c6b5","title":"SYNDROS (DRONABINOL) SOLUTION [BENUVIA OPERATIONS, LLC]"},"ecosystem":[],"_scrapedAt":"2026-03-28T06:25:20.420Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07498023","phase":"PHASE1, PHASE2","title":"EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2025-09-15","conditions":"Fibromyalgia","enrollment":36},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT04859296","phase":"PHASE1","title":"AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2023-02-15","conditions":"Pain, Appetite Loss, Abuse, Drug","enrollment":20},{"nctId":"NCT04025359","phase":"EARLY_PHASE1","title":"Effects of Dronabinol in Opioid Maintained Patients","status":"RECRUITING","sponsor":"Yale University","startDate":"2019-05-31","conditions":"Pain","enrollment":36},{"nctId":"NCT05427630","phase":"PHASE2","title":"Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment","status":"SUSPENDED","sponsor":"University of California, San Diego","startDate":"2023-02-15","conditions":"Migraine, Cannabis, THC","enrollment":20},{"nctId":"NCT06454669","phase":"PHASE2","title":"Dronabinol as an Adjunct for Reducing Pain","status":"RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2024-06-15","conditions":"Low Back Pain, Chronic Pain, Back Injuries","enrollment":75},{"nctId":"NCT06834997","phase":"PHASE2","title":"Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2026-04-01","conditions":"Endometriosis, Endometriosis Related Pain, Endometriosis, Pain","enrollment":""},{"nctId":"NCT06956014","phase":"PHASE3","title":"Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain","status":"NOT_YET_RECRUITING","sponsor":"Vertanical GmbH","startDate":"2026-09","conditions":"Radicular Low Back Pain","enrollment":810},{"nctId":"NCT07471347","phase":"NA","title":"Exploring The Effect Of Cannabidiol On Cannabis Tolerance Using A Novel Vaporiser Device In Heavy Users (Stage 1)","status":"NOT_YET_RECRUITING","sponsor":"King's College London","startDate":"2026-03","conditions":"Cannabis Intoxication","enrollment":10},{"nctId":"NCT06533657","phase":"PHASE2","title":"Unique Treatment of Oncology Pain in Advanced Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ZYUS Life Sciences Inc.","startDate":"2025-06-12","conditions":"Cancer Pain","enrollment":20},{"nctId":"NCT06891235","phase":"","title":"Study of Oral Fluid Testing Approach","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-10-27","conditions":"Cannabis Use, Cannabis Intoxication, Cannabis Use Disorder","enrollment":200},{"nctId":"NCT07459920","phase":"PHASE2","title":"Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2026-04-01","conditions":"Advanced Malignant Solid Tumor","enrollment":156},{"nctId":"NCT04920539","phase":"PHASE1","title":"In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-02-08","conditions":"HIV Infections, Healthy","enrollment":56},{"nctId":"NCT05067387","phase":"PHASE1","title":"Evaluation of Oral THC and CBD in Men and Women","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-04-15","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":22},{"nctId":"NCT05351801","phase":"PHASE2","title":"Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-06-21","conditions":"Neuropathic Pain, Peripheral Neuropathic Pain","enrollment":320},{"nctId":"NCT07422311","phase":"PHASE2, PHASE3","title":"To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"Benuvia Therapeutics Inc.","startDate":"2026-05-01","conditions":"Agitation in Dementia","enrollment":140},{"nctId":"NCT07216690","phase":"PHASE2","title":"Pregnenolone as a Treatment for Cannabis Intoxication","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04-01","conditions":"Cannabis Intoxication","enrollment":20},{"nctId":"NCT05906511","phase":"EARLY_PHASE1","title":"PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-10-17","conditions":"Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability","enrollment":20},{"nctId":"NCT06772753","phase":"PHASE1","title":"Investigation of Psychedelic Effects in Psychoactive Substances","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-05","conditions":"Psychedelic Effects in Healthy Volunteers","enrollment":50},{"nctId":"NCT07417059","phase":"NA","title":"Sex Hormones Impact on Cannabis Response","status":"RECRUITING","sponsor":"Maastricht University","startDate":"2025-06-01","conditions":"Cannabis","enrollment":21},{"nctId":"NCT05287256","phase":"PHASE1","title":"Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2022-05-23","conditions":"Behavioral Pharmacology of Cannabis","enrollment":28},{"nctId":"NCT05432284","phase":"PHASE1","title":"Behavioral Pharmacology of THC and Beta-Myrcene","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-07","conditions":"Cannabis Use","enrollment":32},{"nctId":"NCT07148206","phase":"PHASE3","title":"Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":40},{"nctId":"NCT07401628","phase":"NA","title":"In-Vehicle Real-Time Cannabis Influenced Driving Detection","status":"RECRUITING","sponsor":"University of Bern","startDate":"2026-01-05","conditions":"Driving Under the Influence, Cannabis-impaired Driving","enrollment":45},{"nctId":"NCT07225777","phase":"PHASE2","title":"Sex Differences in Neurobehavioral Response to THC","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-04-01","conditions":"Cannabis Use Disorder","enrollment":40},{"nctId":"NCT03560934","phase":"EARLY_PHASE1","title":"Tetrahydrocannabinol (THC) and Sleep","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-09-01","conditions":"Sleep, THC, Marijuana","enrollment":18},{"nctId":"NCT06222268","phase":"PHASE1","title":"Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2026-03","conditions":"PTSD, Post Traumatic Stress Disorder","enrollment":280},{"nctId":"NCT06589258","phase":"NA","title":"Cannabidiol Into Breastmilk","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-10-06","conditions":"Breast Feeding","enrollment":60},{"nctId":"NCT07368894","phase":"NA","title":"Assessing the Effectiveness of Screening, Brief Intervention, and Referral to Treatment (SBIRT) With Personalized Feedback Intervention to Reduce Polysubstance Impaired Driving in Young Adults Aged 18-30","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2026-01-31","conditions":"Impaired Driving","enrollment":600},{"nctId":"NCT05052541","phase":"PHASE3","title":"Safety and Efficacy of Oral Cannabis in Chronic Spine Pain","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-01","conditions":"Back Pain, Neck Pain","enrollment":157},{"nctId":"NCT05543681","phase":"PHASE2","title":"Clinical Trial on Agitation in Alzheimer's Dementia","status":"RECRUITING","sponsor":"IGC Pharma, LLC","startDate":"2022-10-11","conditions":"Alzheimer Disease, Agitation,Psychomotor, Care Giving Burden","enrollment":164},{"nctId":"NCT06878417","phase":"NA","title":"Cannabinoids for Osteoarthritis Pain Effectiveness Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-15","conditions":"Osteoarthritis of Knee, Osteoarthritis Hip","enrollment":100},{"nctId":"NCT06609083","phase":"PHASE1","title":"Effect of Cannabis on Cigarette Use Behavior","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-01-22","conditions":"Cannabis Use, Tobacco Use, Cigarette Smoking","enrollment":100},{"nctId":"NCT07176208","phase":"PHASE1","title":"Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults","status":"RECRUITING","sponsor":"Food and Drug Administration (FDA)","startDate":"2025-12-29","conditions":"Cannabis, Drug Effects, Driving Performance","enrollment":48},{"nctId":"NCT06261489","phase":"PHASE2","title":"Cannabis (THC vs. CBD) in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Calgary","startDate":"2025-12-05","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT05351905","phase":"NA","title":"Improving Pain Disability With the Use of Oral Cannabinoids","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2022-11-22","conditions":"Chronic Pain, Opioid Use, Cannabis","enrollment":51},{"nctId":"NCT06544291","phase":"PHASE2","title":"Combined THC and CBD for OUD and Chronic Pain","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-22","conditions":"Chronic Pain, Opioid Use Disorder","enrollment":147},{"nctId":"NCT07231965","phase":"PHASE2, PHASE3","title":"Synthetic THC And Blood Pressure","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-02","conditions":"Blood Pressure","enrollment":50},{"nctId":"NCT07214155","phase":"PHASE1","title":"Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04-01","conditions":"Cannabis Intoxication","enrollment":70},{"nctId":"NCT05644262","phase":"PHASE2","title":"Life's End Benefits of cannaBidiol and tetrahYdrocannabinol","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2023-12-18","conditions":"Agitation, Dementia","enrollment":120},{"nctId":"NCT04883255","phase":"EARLY_PHASE1","title":"Cannabis Use, Cognition, and the Endocannabinoid System in HIV","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2023-05-03","conditions":"HIV-1-infection","enrollment":138},{"nctId":"NCT05865470","phase":"PHASE1","title":"Age-dependent Effects of Smoked and Oral Delta-9-THC","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-04-30","conditions":"Pain, Abuse, Drug, Intoxication; Cannabinoids","enrollment":103},{"nctId":"NCT06099379","phase":"PHASE1, PHASE2","title":"Modulation of THC Effects by CBD: a Dose-ranging Study","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2024-06-27","conditions":"Cannabis, THC","enrollment":100},{"nctId":"NCT07296874","phase":"PHASE2","title":"Acute Effects of Cannabis on Cognition and Affect","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-02","conditions":"Cannabis Use","enrollment":90},{"nctId":"NCT06859710","phase":"PHASE1","title":"THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-11-05","conditions":"Abuse, Drug, Pain","enrollment":30},{"nctId":"NCT01964404","phase":"PHASE1","title":"Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2014-07","conditions":"Schizophrenia, Dual Diagnosis, Psychotic Disorder","enrollment":263},{"nctId":"NCT06731894","phase":"PHASE2","title":"Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-10-03","conditions":"Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma","enrollment":120},{"nctId":"NCT07199218","phase":"PHASE2","title":"Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism","status":"RECRUITING","sponsor":"Bazelet Nehushtan LtD.","startDate":"2025-10-05","conditions":"Autism, Autism Spectrum Disorder","enrollment":78},{"nctId":"NCT06034314","phase":"PHASE1","title":"Oral Dronabinol-HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-09-21","conditions":"HIV","enrollment":160},{"nctId":"NCT03633721","phase":"PHASE2","title":"Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2020-10-23","conditions":"HIV, AIDS, Aging","enrollment":25},{"nctId":"NCT04800159","phase":"PHASE2","title":"Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Diego","startDate":"2021-02-19","conditions":"HIV, Cannabis Use","enrollment":40},{"nctId":"NCT06236815","phase":"EARLY_PHASE1","title":"High Confusion: Cannabis & Driving","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2025-01-25","conditions":"Impairment, Cognitive, Impairment of Attention, Impairment, Psychomotor","enrollment":5},{"nctId":"NCT06647524","phase":"PHASE2","title":"Pilot fMRI Studies of Aging-Related Effects of THC","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-07-01","conditions":"THC","enrollment":10},{"nctId":"NCT06859723","phase":"PHASE1","title":"High Potency Cannabis: Acute and Protracted Effects","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-07-03","conditions":"Abuse Cannabis, Pain, Pharmacokinetics","enrollment":30},{"nctId":"NCT05519111","phase":"PHASE2","title":"Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2025-04-03","conditions":"Sickle Cell Disease","enrollment":60},{"nctId":"NCT02069366","phase":"NA","title":"Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2014-11","conditions":"Post-Traumatic Stress Disorder","enrollment":86},{"nctId":"NCT04816994","phase":"PHASE3","title":"Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2018-01-07","conditions":"Acute Radicular Back Pain, Cannabis","enrollment":200},{"nctId":"NCT06381180","phase":"PHASE1, PHASE2","title":"Warrior CARE: Cannabis Behavioral Health","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2025-09-22","conditions":"Post Traumatic Stress Disorder, Cannabis Use, Suicide","enrollment":500},{"nctId":"NCT06218550","phase":"PHASE1","title":"Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2024-07-01","conditions":"Cannabis","enrollment":30},{"nctId":"NCT06758596","phase":"EARLY_PHASE1","title":"Research Investigating Drug Effects-2 (RiDE-2)","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2026-07-15","conditions":"Cannabis Use, Substance Use Disorder (SUD), Healthy","enrollment":144},{"nctId":"NCT06293040","phase":"PHASE1","title":"Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-09-26","conditions":"Cannabis Intoxication, Alcohol Intoxication","enrollment":90},{"nctId":"NCT06477952","phase":"PHASE1, PHASE2","title":"DRonabinol Treatment of OSA","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-08-25","conditions":"Obstructive Sleep Apnea","enrollment":120},{"nctId":"NCT03948074","phase":"PHASE2","title":"Cannabis For Cancer-Related Symptoms","status":"COMPLETED","sponsor":"Pippa Hawley","startDate":"2021-02-01","conditions":"Pain, Nausea, Anxiety","enrollment":91},{"nctId":"NCT04992624","phase":"PHASE2","title":"Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee","status":"RECRUITING","sponsor":"Steven E Harte, PhD","startDate":"2022-02-22","conditions":"Osteoarthritis, Knee, Osteoarthritis of the Knee","enrollment":200},{"nctId":"NCT07146945","phase":"PHASE1","title":"A Study Testing the Safety and Effects of Single Doses of S1-221 in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Delphian Therapeutics Australia Pty, Ltd","startDate":"2025-08-30","conditions":"Healthy Participants","enrollment":84},{"nctId":"NCT03008005","phase":"PHASE4","title":"Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2017-06-01","conditions":"PostTraumatic Stress Disorder","enrollment":46},{"nctId":"NCT04374773","phase":"PHASE4","title":"Effects of Pregnancy-associated Hormones on THC Metabolism in Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2020-10-19","conditions":"Pregnancy Related, Cannabis Use","enrollment":12},{"nctId":"NCT05664763","phase":"EARLY_PHASE1","title":"Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate Homeostasis","status":"TERMINATED","sponsor":"Yale University","startDate":"2023-03-01","conditions":"Cannabis Use Disorder","enrollment":6},{"nctId":"NCT06948136","phase":"PHASE1","title":"Acute Effects of THC in Older Adult","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-06-06","conditions":"Age-related Cognitive Decline","enrollment":60},{"nctId":"NCT04448808","phase":"PHASE2","title":"Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2020-10-01","conditions":"Posttraumatic Stress Disorder","enrollment":170},{"nctId":"NCT07091747","phase":"PHASE1, PHASE2","title":"Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2025-04-07","conditions":"Alzheimer Disease (AD)","enrollment":61},{"nctId":"NCT06475001","phase":"PHASE2","title":"Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain","status":"COMPLETED","sponsor":"Vertanical GmbH","startDate":"2024-06-28","conditions":"Chronic Non-specific Low Back Pain","enrollment":652},{"nctId":"NCT05477875","phase":"PHASE2","title":"Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control","status":"COMPLETED","sponsor":"University of Florida","startDate":"2024-02-01","conditions":"Photorefractive Keratectomy, Myopia, Hyperopia","enrollment":35},{"nctId":"NCT06471647","phase":"EARLY_PHASE1","title":"Effects of Drugs on Stress Memories","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2024-07-01","conditions":"Delta-9-tetrahydrocannabinol (THC), Stress","enrollment":36},{"nctId":"NCT07107607","phase":"","title":"Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2021-03-19","conditions":"Cancer, Cancer (With or Without Metastasis)","enrollment":50},{"nctId":"NCT07100314","phase":"","title":"Preoperative Toxicological Screening on Perioperative Anesthetic Management","status":"COMPLETED","sponsor":"General Committee of Teaching Hospitals and Institutes, Egypt","startDate":"2023-12-01","conditions":"Toxicology, Bariatric Surgery Analgesia, Bariatric Surgery","enrollment":1260},{"nctId":"NCT05269628","phase":"PHASE2","title":"Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype","status":"RECRUITING","sponsor":"Tiffany J. Braley, MD, MS","startDate":"2022-03-25","conditions":"Multiple Sclerosis, Sleep, Pain","enrollment":166},{"nctId":"NCT06967051","phase":"NA","title":"The Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults","status":"RECRUITING","sponsor":"Sobereye Inc.","startDate":"2025-05-22","conditions":"Cannabis Intoxication, Drug Effects","enrollment":20},{"nctId":"NCT04080427","phase":"PHASE1","title":"Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2021-04-15","conditions":"Posttraumatic Stress Disorder","enrollment":102},{"nctId":"NCT06058702","phase":"PHASE1","title":"Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-09-16","conditions":"Schizophrenia, Cannabis Use Disorder","enrollment":215},{"nctId":"NCT06588972","phase":"PHASE2","title":"Analgesic Effects of a Treatment With Cannabis Sativa Extract in Patients With Knee Osteoarthritis - CANOA (Cannabis for Osteoarthritis)","status":"COMPLETED","sponsor":"Federal University of Latin American Integration","startDate":"2024-01-01","conditions":"OSTEOARTHRITIS OF THE KNEE","enrollment":45},{"nctId":"NCT04856566","phase":"EARLY_PHASE1","title":"Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-07-28","conditions":"Marijuana Impairment, Alcohol Impairment","enrollment":41},{"nctId":"NCT06601218","phase":"PHASE1","title":"Impact of Daily Oral Cannabis Doses in Patients With Cancer","status":"RECRUITING","sponsor":"Shanna Babalonis, PhD","startDate":"2025-06-17","conditions":"Cancer, Cancers, Pain","enrollment":80},{"nctId":"NCT05820685","phase":"PHASE4","title":"Dronabinol On the Pain Experience","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-07-27","conditions":"Trauma Injury","enrollment":484},{"nctId":"NCT02781519","phase":"PHASE1","title":"Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans","status":"RECRUITING","sponsor":"Yale University","startDate":"2015-06","conditions":"Cannabis","enrollment":100},{"nctId":"NCT02102113","phase":"EARLY_PHASE1","title":"Probing the Cannabinoid System in Individuals With a Family History of Psychosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2014-01","conditions":"Psychosis, Cannabis Use, THC","enrollment":21},{"nctId":"NCT05641766","phase":"PHASE2","title":"Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2025-08-31","conditions":"THC","enrollment":50},{"nctId":"NCT02407808","phase":"PHASE1","title":"Cannabinoids, Learning, and Memory","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2015-02","conditions":"Cannabis, Psychotic Disorders","enrollment":80},{"nctId":"NCT02811510","phase":"PHASE1","title":"Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I","status":"RECRUITING","sponsor":"Yale University","startDate":"2016-06","conditions":"Cannabis","enrollment":40},{"nctId":"NCT06358144","phase":"NA","title":"Cannabis Edibles Packaging Imagery Experiment","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2024-05-23","conditions":"Cannabis Use","enrollment":1260},{"nctId":"NCT05337033","phase":"PHASE2","title":"Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2024-10-11","conditions":"Chronic Migraine","enrollment":20},{"nctId":"NCT06570928","phase":"PHASE2","title":"Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease","status":"COMPLETED","sponsor":"Federal University of Latin American Integration","startDate":"2024-08-13","conditions":"Alzheimer Disease","enrollment":72},{"nctId":"NCT04130633","phase":"PHASE1","title":"Behavioral Pharmacology of THC and Alpha-pinene","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-11-05","conditions":"THC, Alpha-pinene","enrollment":33},{"nctId":"NCT04512365","phase":"EARLY_PHASE1","title":"Reward and Drug Effects on Mood and Brain Response","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2021-03-16","conditions":"Cannabis Use, Healthy","enrollment":141},{"nctId":"NCT06378957","phase":"PHASE1","title":"Behavioral Pharmacology of Orally Administered THC and D-limonene","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-14","conditions":"Subjective Drug Effects, THC, D-limonene","enrollment":65},{"nctId":"NCT04596826","phase":"PHASE2","title":"The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2020-11-11","conditions":"Retinal Blood Flow","enrollment":51},{"nctId":"NCT05126888","phase":"PHASE2","title":"SCI-110 in the Treatment of Tourette Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Neurothera Labs Inc.","startDate":"2025-08","conditions":"Tourette Syndrome","enrollment":164},{"nctId":"NCT02792257","phase":"PHASE2","title":"Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-03-01","conditions":"Alzheimer's Disease","enrollment":84},{"nctId":"NCT05322213","phase":"PHASE1","title":"THC Effects on Glucose in Type 2 Diabetes","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-08-22","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT05335252","phase":"PHASE3","title":"Dronabinol After Arthroscopic Surgery","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2022-06-28","conditions":"Knee Osteoarthritis, Knee Injuries, Meniscus Tear","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[{"date":"20210322","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20180914","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20180412","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20170525","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20161208","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20240517","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20220921","type":"SUPPL","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"},{"date":"20160701","type":"ORIG","sponsor":"WELLHOUSE PHARMA","applicationNumber":"NDA205525"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Syndros","genericName":"Syndros","companyName":"University of Arizona","companyId":"university-of-arizona","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":13,"withResults":1},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}